 |
市場調査レポート
商品コード
1447934
消費者直接遺伝子検査の世界市場規模、シェア、成長分析、検査タイプ別、用途別 - 産業予測、2024年～2031年Global Direct-to-Consumer Genetic Testing Market Size, Share, Growth Analysis, By Test type(Ancestry testing, health & wellness testing), By Application(Personal use, medical use and forensic use) - Industry Forecast 2024-2031 |
||||||
| 消費者直接遺伝子検査の世界市場規模、シェア、成長分析、検査タイプ別、用途別 - 産業予測、2024年～2031年 |
|
出版日: 2024年02月27日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
消費者直接遺伝子検査の世界市場規模は、2022年に15億5,000万米ドルと評価され、2023年の19億3,000万米ドルから2031年には112億2,000万米ドルに成長し、予測期間中（2024-2031年）のCAGRは24.6％で成長する見通しです。
消費者直接遺伝子検査の世界市場は、人々が自分の遺伝子データを入手し理解する方法を変革しつつあります。この市場を利用することで、人々は簡単かつ便利に自分の遺伝的体質と直接対話し、遺伝、健康リスク、独自のウェルネスについての詳細を知ることができます。市場成長の原動力となっているのは、消費者の遺伝子情報に対する好奇心の高まりと自己発見への欲求です。技術開発と好奇心の高まりにより、遺伝子検査はより広く利用できるようになり、価格も手ごろになった。さらに、個別化医療と予防ヘルスケアが重視されるようになったため、オーダーメイドの遺伝学的洞察に対するニーズが高まっています。データの安全性とプライバシーに対する懸念が事業拡大を妨げています。遺伝子データは私的で機密性が高いため、データが安全に保管され、責任を持って使用されるという消費者の信頼を維持することが不可欠です。さらに、遺伝子検査の結果の解釈や理解には複雑さが伴うため、顧客が誤解したり混乱したりする可能性もあります。この分野で最も一般的な動向の一つは、ウェアラブル技術やデジタルヘルスプラットフォームと遺伝子検査の組み合わせです。この連携により、人々は遺伝的な健康要因を追跡・モニターすることができ、その結果、オーダーメイドの健康介入を行うことができます。検査結果に遺伝カウンセリング・サービスを組み込むことも新しい動向であり、収集した遺伝データの分析と活用において、顧客に専門的なアドバイスと支援を提供します。消費者に直接販売される遺伝子検査市場には、拡大と革新のチャンスが豊富にあります。データ分析とゲノム研究の発展により、遺伝子検査の精度と予測能力を向上させることが可能です。さらに、検査対象となる遺伝子疾患や特徴の種類を増やすことで、顧客により多くの利益をもたらすことができます。さらに、遺伝子検査の利点と制限に関する教育と認識を促進することで、顧客の知識を増やし、市場の成長を刺激することができます。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
消費者直接遺伝子検査の世界市場：検査タイプ別
- 市場概要
- 祖先検査
- 健康とウェルネスの検査
- 特性検査
- 親子検査
消費者直接遺伝子検査の世界市場：用途別
- 市場概要
- 個人使用
- 医療用途と法医学用途
消費者直接遺伝子検査の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- 23andMe（US）
- AncestryDNA（US）
- MyHeritage（US）
- FamilyTreeDNA（US）
- Living DNA（UK）
- Helix（US）
- Color Genomics（US）
- Veritas Genetics（US）
- Orig3n（US）
- Pathway Genomics（US）
- Dante Labs（UK）
- Gene by Gene（US）
- Nebula Genomics（US）
- GeneSight（US）
- Counsyl（US）
- Invitae Corporation（US）
- Genomics England（UK）
- Kailos Genetics（US）
- African Ancestry（US）
- Toolbox Genomics（US）
Global Direct-to-Consumer Genetic Testing Market size was valued at USD 1.55 billion in 2022 and is poised to grow from USD 1.93 billion in 2023 to USD 11.22 billion by 2031, growing at a CAGR of 24.6% during the forecast period (2024-2031).
The global market for direct-to-consumer genetic testing is transforming how people obtain and comprehend their genetic data. With the use of this market, people may easily and conveniently interact directly with their genetic makeup and learn more about their heritage, health risks, and unique wellness. Market growth is driven by consumers' growing curiosity about their genetic information and desire for self-discovery. Genetic testing is now more widely available and reasonably priced thanks to technological developments and increased curiosity. Additionally, there is a greater need for tailored genetic insights due to the growing emphasis on personalized medicine and preventive healthcare. Concern over data security and privacy is impeding business expansion. Because genetic data is private and sensitive, it is essential to preserve consumer trust that the data is stored securely and used responsibly. Furthermore, customers may misunderstand or become confused as a result of the complexity involved in interpreting and comprehending the results of genetic tests. One of the most common trends in this sector is the combination of wearable technology and digital health platforms with genetic testing. Through this connection, people can track and monitor their genetically predisposed health factors, resulting in tailored wellness interventions. Incorporating genetic counselling services with test results is another new trend that offers customers expert advice and assistance in analysing and utilizing the genetic data they have collected. The market for genetic tests sold directly to consumers offers a wealth of chances for expansion and innovation. It is possible to improve the precision and prediction ability of genetic tests thanks to developments in data analytics and genomic research. Furthermore, increasing the variety of genetic disorders and features that are tested for can benefit customers more. Furthermore, promoting education and awareness about the advantages and restrictions of genetic testing can increase customer knowledge and stimulate market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Direct-to-Consumer Genetic Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Direct-to-Consumer Genetic Testing Market Segmental Analysis
Global Genetic Testing Direct-to-Consumer Based on test type, application, and geography, the market is divided into segments. The market is divided into four segments based on the type of test: characteristics testing, parental testing, health and wellness testing, and ancestry testing. The market is divided into three categories based on application: forensic, medicinal, and personal. The market is divided into Latin America, Middle East and Africa, Asia Pacific, North America, and Europe.
Drivers of the Global Direct-to-Consumer Genetic Testing Market
The growing demand for individualized healthcare among consumers is a major factor driving the direct-to-consumer genetic testing market. In order to make more educated decisions about illness prevention, lifestyle modifications, and individualized treatment options, people are become more proactive about managing their health and are looking for a deeper understanding of their genetic predispositions. For instance, people can choose to undergo genetic testing to determine their likelihood of contracting inherited diseases like Alzheimer's or breast cancer, allowing them to take preventative or early detection actions.
Restraints in the Global Direct-to-Consumer Genetic Testing Market
The market for direct-to-consumer genetic testing is beset by ethical and regulatory issues. Without the assistance of healthcare professionals, consumers may misunderstand or become confused when complicated genetic information is interpreted and communicated to them. Due to the possibility of sensitive information being misused or unauthorized access due to the commercialization and accessibility of genetic information, concerns are being raised about the security and privacy of personal genetic data. Regulations are being developed by regulatory organizations to guarantee appropriate management and consumer protection in the direct-to-consumer genetic testing market.
Market Trends of the Global Direct-to-Consumer Genetic Testing Market
There is a tendency in the direct-to-consumer genetic testing business toward the expansion of applications beyond genealogy and ancestry testing. Businesses are starting to offer more and more tests that reveal information on wellness, pharmacogenomics, genetic problem carriers, and health-related features. To improve medicine selection and dosage, for example, genetic testing is now available to ascertain an individual's response to specific treatments.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Direct-to-Consumer Genetic Testing Market by Test type
- Market Overview
- Ancestry testing
- health & wellness testing
- traits testing
- and parental testing
Global Direct-to-Consumer Genetic Testing Market by Application
- Market Overview
- Personal use
- medical use and forensic use
Global Direct-to-Consumer Genetic Testing Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- 23andMe (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AncestryDNA (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MyHeritage (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FamilyTreeDNA (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Living DNA (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Helix (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Color Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Veritas Genetics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orig3n (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pathway Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dante Labs (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gene by Gene (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nebula Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GeneSight (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Counsyl (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Invitae Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genomics England (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kailos Genetics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- African Ancestry (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Toolbox Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
